HGF-independent Potentiation of EGFR Action by c-Met

The c-Met receptor is a potential therapeutic target for non-small cell lung cancer (NSCLC). Signaling interactions between c-Met and the mutant Epidermal Growth Factor Receptor (EGFR) have been studied extensively, but signaling intermediates and biological consequences of lateral signaling to c-Me...

Descripción completa

Detalles Bibliográficos
Autores principales: Dulak, Austin M., Gubish, Christopher T., Stabile, Laura P., Henry, Cassandra, Siegfried, Jill M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: 2011
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3126872/
https://www.ncbi.nlm.nih.gov/pubmed/21423210
http://dx.doi.org/10.1038/onc.2011.84

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3126872/
https://www.ncbi.nlm.nih.gov/pubmed/21423210
http://dx.doi.org/10.1038/onc.2011.84

Ejemplares similares